| Revenue growth | FY26 Consolidated: -1% YoY to ₹957 cr |
|---|---|
| Margins | Consolidated FY26 EBITDA margin at 37.7% vs 40.8% YoY |
| Demand visibility | HALS sales momentum continues; base business rebound visible |
Growth
FY26 consolidated revenue fell 1% YoY; PAT dropped 13%. Q4 standalone EBITDA grew 22% QoQ.
Outlook
Final dividend of ₹4/share; ₹220 cr capex in FY26 for CFCL; focusing on new HALS series.
Risks
Challenging market conditions; potential raw material price volatility affecting margins.
Earnings Call filed with BSE, NSE: CLEAN. Summary written with AI assistance from the document.
Clean Science & Technology Ltd: key numbers
- Share price
- ₹807.25
- Market cap
- ₹8,580 Cr
- Revenue (annual)
- ₹956.5 Cr
- Net profit (annual)
- ₹229.7 Cr
- P/E (TTM)
- 36.8×Sector 37.5×
- Promoter holding
- 51.29%+0.00% QoQ
- FII holding
- 13.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Clean Science & Technology Ltd
All →Clean Science & Technology Credit Rating
CRISIL reaffirmed Clean Science's long-term rating at AA-/Stable and short-term at A1+. The rating action signals continued stable credit quality with no change.
Clean Science & Technology Legal & Regulatory
GST authorities initiated search and seizure proceedings at the company's premises. The company reports no material impact on financials or business operations at this stage.
Clean Science & Technology Acquisition Worth ₹50 Cr
Clean Science and Technology invested Rs. 50.00 Crore to subscribe to additional equity shares of its wholly-owned subsidiary, Clean Fino-Chem Limited, for project funding.
- Value
- ₹50.00 Cr
Clean Science & Technology Management Change
Clean Science and Technology Limited has appointed Mr. Krishnakumar Satyanarain Saboo as an Executive Director, effective August 1, 2026, for a five-year term.
Clean Science & Technology Annual General Meeting
Clean Science and Technology Limited held its 23rd AGM on September 12, 2026. Shareholders approved all agenda items, including the final dividend declaration.
Clean Science & Technology Earnings Call Transcript: Key Takeaways
Clean Science reports record consolidated sales driven by the HALS segment scaling up, though legacy business faced raw material supply disruptions. Management is aggressively pivoting toward high-margin, advanced HALS chemistry via a new Swiss strategic collaboration.
- Call
- Guides 67% growth